Background <p>This study was aimed to evaluate the impact of multivisceral resection (MVR) on the oncologic outcomes of patients with locally advanced colorectal cancer.</p> Methods <p>We conducted a retrospective review of patients who underwent surgical resection between 2011 and 2020. Patients were divided into two groups: the MVR group and the standard resection group. Prognostic factors were compared, and the effect of MVR on oncologic outcomes was assessed.</p> Results <p>Among 625 patients, 108 underwent MVR. The MVR group showed a significantly lower rate of lymph node metastasis (51.9% vs. 72.5%, <i>p</i> &lt; 0.001), lymphovascular invasion (25.9% vs. 42.8%, <i>p</i> = 0.001), and perineural invasion (45.4% vs. 73.2%, <i>p</i> &lt; 0.001) compared to the standard resection group. Postoperative complications were more frequent in the MVR group (57.4% vs. 26.9%, <i>p</i> &lt; 0.001). Three-year disease-free survival (68.6% vs. 62.7%, <i>p</i> = 0.743) and overall survival (OS) (80.9% vs. 85.0%, <i>p</i> = 0.290) were comparable between the two groups. Multivariable analysis identified lymph node metastasis, perineural invasion, R2 resection, and absence of adjuvant chemotherapy as independent poor prognostic factors for OS.</p> Conclusions <p>The MVR group showed a significantly lower rate of lymph node metastasis and comparable oncologic outcomes. Therefore, when adjacent organ invasion is suspected, an aggressive en-bloc MVR should be considered to achieve radical resection.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Oncologic outcomes of multivisceral resection for locally advanced colorectal cancer: a single-center retrospective cohort study

  • Jaram Lee,
  • Hyeung-min Park,
  • Soo Young Lee,
  • Chang Hyun Kim,
  • Hyeong Rok Kim

摘要

Background

This study was aimed to evaluate the impact of multivisceral resection (MVR) on the oncologic outcomes of patients with locally advanced colorectal cancer.

Methods

We conducted a retrospective review of patients who underwent surgical resection between 2011 and 2020. Patients were divided into two groups: the MVR group and the standard resection group. Prognostic factors were compared, and the effect of MVR on oncologic outcomes was assessed.

Results

Among 625 patients, 108 underwent MVR. The MVR group showed a significantly lower rate of lymph node metastasis (51.9% vs. 72.5%, p < 0.001), lymphovascular invasion (25.9% vs. 42.8%, p = 0.001), and perineural invasion (45.4% vs. 73.2%, p < 0.001) compared to the standard resection group. Postoperative complications were more frequent in the MVR group (57.4% vs. 26.9%, p < 0.001). Three-year disease-free survival (68.6% vs. 62.7%, p = 0.743) and overall survival (OS) (80.9% vs. 85.0%, p = 0.290) were comparable between the two groups. Multivariable analysis identified lymph node metastasis, perineural invasion, R2 resection, and absence of adjuvant chemotherapy as independent poor prognostic factors for OS.

Conclusions

The MVR group showed a significantly lower rate of lymph node metastasis and comparable oncologic outcomes. Therefore, when adjacent organ invasion is suspected, an aggressive en-bloc MVR should be considered to achieve radical resection.